Endothelin-receptor antagonist treatment of portopulmonary hypertension Lukas Hinterhuber, Ivo W. Graziadei, Christian M. Kähler, Werner Jaschke, Wolfgang Vogel Clinical Gastroenterology and Hepatology Volume 2, Issue 11, Pages 1039-1042 (November 2004) DOI: 10.1016/S1542-3565(04)00466-5 Copyright © 2004 American Gastroenterological Association Terms and Conditions
Figure 1 (A) Hemodynamic measurements at the beginning and after initiation of bosentan therapy. (B) Measurements of HVPG at the beginning and after initiation of bosentan therapy. Clinical Gastroenterology and Hepatology 2004 2, 1039-1042DOI: (10.1016/S1542-3565(04)00466-5) Copyright © 2004 American Gastroenterological Association Terms and Conditions